Skip to main content
Premium Trial:

Request an Annual Quote

IBBL Receives ISO Certification

NEW YORK (GenomeWeb) – The Integrated BioBank of Luxembourg today announced it has received ISO 9001 certification from the European Society for Certification of Management Systems.

IBBL is now certified for the acquisition, validation, processing, storage, administration, and distribution of biological material to public or private end users. The independent, non-profit biobank also received NF S96-900 certification, the French standard for management of biological resources.

The certifications "will increase the biobank's visibility and reputation beyond the borders of Luxembourg," IBBL CEO Catherine Larue said. "The next step will be accreditation to ISO17025, the international norm for the requirements for the competence of testing laboratories."

Earlier this year, IBBL signed a performance contract with Luxembourg's Ministry of Higher Education and Research that will run until 2017. 

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.